{"filing":{"accession_number":"0000009326-26-000026","cik":"0000009326","ticker":"BCPC","company_name":"BALCHEM CORP","form":"8-K","filing_date":"2026-07-31","report_date":"2026-07-31","primary_document":"bcpc-20260731.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/9326/000000932626000026/bcpc-20260731.htm"},"events":[{"id":22708,"run_id":20543,"accession_number":"0000009326-26-000026","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Balchem Corporation disclosed quarterly financial results for Q2 2026 (ended June 30, 2026) via press release attached as Exhibit 99.1. The disclosure reports net sales of $284.0 million (up 11.2% YoY), net earnings of $44.6 million (up 16.6% YoY), adjusted EBITDA of $77.9 million (up 12.6% YoY), and diluted EPS of $1.39 (up from $1.17). This is a standard quarterly earnings release filed under Item 2.02, with material financial results affecting investor assessment of the company's performance.","company_name":"BALCHEM CORP","ticker":"BCPC","filing_date":"2026-07-31","form":"8-K","submitted_at":null,"items":[{"id":22730,"accession_number":"0000009326-26-000026","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Balchem Corporation disclosed quarterly financial results for Q2 2026 (ended June 30, 2026) via press release attached as Exhibit 99.1. The disclosure reports net sales of $284.0 million (up 11.2% YoY), net earnings of $44.6 million (up 16.6% YoY), adjusted EBITDA of $77.9 million (up 12.6% YoY), and diluted EPS of $1.39 (up from $1.17). This is a standard quarterly earnings release filed under Item 2.02, with material financial results affecting investor assessment of the company's performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-02T02:19:28.659839+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":22730,"accession_number":"0000009326-26-000026","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Balchem Corporation disclosed quarterly financial results for Q2 2026 (ended June 30, 2026) via press release attached as Exhibit 99.1. The disclosure reports net sales of $284.0 million (up 11.2% YoY), net earnings of $44.6 million (up 16.6% YoY), adjusted EBITDA of $77.9 million (up 12.6% YoY), and diluted EPS of $1.39 (up from $1.17). This is a standard quarterly earnings release filed under Item 2.02, with material financial results affecting investor assessment of the company's performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-02T02:19:28.659839+00:00","company_name":"BALCHEM CORP","ticker":"BCPC","filing_date":"2026-07-31"}]}